ArticleFrontiers in neuroscience2025
Transcriptomic analysis of identical twins with different onset ages of adrenoleukodystrophy.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Adrenoleukodystrophy (ALD) is a rare X-linked neurogenetic disease caused by mutations in the ATP-binding cassette subfamily D member 1 ( Methods: The identification of differentially expressed genes (DEGs), set theory analysis, gene enrichment analysis, and classification statistics of expression trends have been executed to acquire potential candidate genes inducing the onset and severity of ALD in patients. The study cohort comprised eight individuals: two normal children, two pediatric twins with ALD, the twins' mother, their adult uncle with ALD, the twins'grandmother, and one normal adult. Results: Five distinct sets of differentially expressed genes (DEGs) were identified using whole blood samples from a family of identical twins with different onset ages and ABCD1 exon 2 deletions. Then, 39 DEGs of A ∩ B ∩ C - D and A ∩ B - D, as well as 425 DEGs of C ∩ E, were considered as genes relating to the onset and severity of ALD. In particular, C4BPA, TPBG, CEP112, CHST15, SMAD1, IL-26, and Discussion: The information on candidate genes of this study was considered crucial for preliminarily exploring the molecular mechanisms related to the onset and severity of ALD, which offered novel insights and research directions for mitigating and treating the development of ALD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.